Your browser doesn't support javascript.
loading
Recent advances and limitations of mTOR inhibitors in the treatment of cancer.
Ali, Eunus S; Mitra, Kangkana; Akter, Shamima; Ramproshad, Sarker; Mondal, Banani; Khan, Ishaq N; Islam, Muhammad Torequl; Sharifi-Rad, Javad; Calina, Daniela; Cho, William C.
Afiliação
  • Ali ES; College of Medicine and Public Health, Flinders University, Bedford Park, 5042, Australia.
  • Mitra K; Gaco Pharmaceuticals, Dhaka, 1000, Bangladesh.
  • Akter S; Department of Biochemistry and Molecular Genetics, and Simpson Querrey Institute for Epigenetics, Northwestern University Feinberg School of Medicine, 303 E Superior St, Chicago, IL, 60611, USA.
  • Ramproshad S; Faculty of Medicine and Pharmacy, Université Grenoble Alpes, Grenoble, France.
  • Mondal B; Department of Bioinformatics and Computational Biology, George Mason University, Fairfax, VA, 22030, USA.
  • Khan IN; Department of Pharmacy, Ranada Prasad Shaha University, Narayanganj, 1400, Bangladesh.
  • Islam MT; Department of Pharmacy, Ranada Prasad Shaha University, Narayanganj, 1400, Bangladesh.
  • Sharifi-Rad J; Institute of Basic Medical Sciences, Khyber Medical University, Peshawar, 25100, Pakistan.
  • Calina D; Department of Pharmacy, Life Science Faculty, Bangabandhu Sheikh Mujibur Rahman Science and Technology University, Gopalganj, 8100, Bangladesh.
  • Cho WC; Facultad de Medicina, Universidad del Azuay, Cuenca, Ecuador. javad.sharifirad@gmail.com.
Cancer Cell Int ; 22(1): 284, 2022 Sep 15.
Article em En | MEDLINE | ID: mdl-36109789
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Austrália
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Austrália